How rival opioid makers sought to cash in on alarm over OxyContin’s dangers

As Purdue Pharma faced mounting criticism over deaths linked to OxyContin, rival drug makers saw a chance to boost sales by stepping up marketing of similarly dangerous painkillers, such as fentanyl, morphine and methadone, Purdue internal documents reveal.